home / stock / dbvt / dbvt news


DBVT News and Press, DBV Technologies S.A. From 03/05/21

Stock Information

Company Name: DBV Technologies S.A.
Stock Symbol: DBVT
Market: NASDAQ
Website: dbvtechnologies.com

Menu

DBVT DBVT Quote DBVT Short DBVT News DBVT Articles DBVT Message Board
Get DBVT Alerts

News, Short Squeeze, Breakout and More Instantly...

DBVT - DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference

Montrouge, France, March 5, 2021 DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced th...

DBVT - DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results

Montrouge, France, March 3, 2021 DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced tha...

DBVT - DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021

Montrouge, France, March 1, 2020 DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021 DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the Com...

DBVT - DBV Technologies to Participate in Upcoming AAAAI 2021 Congress

Montrouge, France, February 24, 2021 DBV Technologies to Participate in Upcoming AAAAI 2021 Congress DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced upcoming participatio...

DBVT - DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer

Montrouge, France, February 22, 2021 DBV Technologies Announces Appointment of Michele F. Robertson as Chief Legal Officer DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced...

DBVT - DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference

Montrouge, France, February 19, 2021 DBV Technologies to Participate in SVB Leerink Global Partners Healthcare Conference DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced ...

DBVT - Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021

Monthly information regarding the total number of voting rights and total number of shares of the Company as of January 31, 2021 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : NYSE Euronext Paris ISIN C...

DBVT - IBM, GSAT among premarket losers

Senseonics Holdings (SENS) -16% after raising size of stock offering.Global Ship Lease (GSL) -14% after announcing public offering.Globalstar (GSAT) -13% after Morgan Stanley cuts to underweight on valuation.Broadwind (BWEN) -13% after guiding Q4 revenu...

DBVT - DBV Technologies cut to sell at SocGen, shares down 8%

Societe Generale analyst Delphine Le Louet downgraded DBV Technologies (DBVT) to sell from hold.PT set to €8.40, implies a 22% decrease from last price.DBV Tech has gained ~47% over the past six months. Both Wall Street Analysts and Quant Rating is Bullish.Earlier this month,...

DBVT - GME, LAC, AMC and COHR among premarket gainers

Tenax Therapeutics, Inc. (TENX) +70% after announcing acquisition of PH Precision Med.Aclaris Therapeutics (ACRS) +66% on positive data from mid-stage rheumatoid arthritis.Minerva Neurosciences (NERV) +42% on announcing sale of Seltorexant Royalty for up to $155M.China Natural ...

Previous 10 Next 10